I am pleased with the growth and accomplishments related to the Company’s key strategic objectives to set a new standard in neurovascular access and delivery,” said Brian Martin, co-founder and CEO of ...

The growing prevalence of chronic diseases like cancer and diabetes is driving increasing innovation in medical device ...

The FDA announced today that a Philips recall involving remote cardiac monitoring software is Class I, its most serious ...

Discover the latest FDA-cleared orthopedic and spine devices and technologies, including robotics, implants, and bone graft systems.

FDA recently issued two draft guidance documents discussing: (1) the use of artificial intelligence (AI) to produce information to support ...

Q&M Dental disposed of 51% interest in EM2AI in March 2024, resulting in a decrease in equity interest from 100% to 49% ...

Commissioner Robert Califf, M.D., and other senior FDA officials recently published a “Special Communication” in JAMA describing FDA’s concerns with the use of AI in medical product development, ...

The rate of warnings initiated by the FDA continues to rise in the pharma and medical device industries. Knowing how to best ...

The Food and Drug Administration announced that Philips recalled the software following 109 reported injuries and two ...

Here are three recent recalls reported to the FDA: ...

The company will now be able to sell and distribute in Thailand, the Philippines, Vietnam, and Indonesia. Q&M Dental Group, ...

Absci recently received a $20 million PIPE investment from AMD that improves its runway and R&D platform with AI. See why I ...